CVS Health Gains 18% in 2026 as Wall Street Sees Another 22% Upside

1 articles · Updated · Yahoo Finance · Aug 22

CVS shares have climbed more than 18% this year, outpacing the S&P 500's sub-13% gain, while analysts' consensus target of $114.59 implies roughly 22% more upside.
Three 2026 quarterly reports all beat revenue and profit estimates, with adjusted EPS at $2.57 versus $2.21 in the first quarter and $2.58 versus $1.83 in the second.
CVS also raised full-year revenue and earnings guidance after both quarters, reinforcing investor confidence that the earnings strength can continue.
Aetna's medical benefit ratio fell from 94.8% in late 2025 to 84.6% in the first quarter and 87.4% in the next two periods, helping healthcare benefits operating income jump 52% to over $3 billion and 85% to $2.4 billion.